Zimhi Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Zimhi
B
- B & O Supprettes (belladonna / opium)
- B-Tuss (chlorpheniramine / hydrocodone / phenylephrine)
- belladonna / opium
- binimetinib
- Biotussin DAC (codeine / guaifenesin / pseudoephedrine)
- Bitex Liquid (codeine / guaifenesin)
- BPM PE HC (brompheniramine / hydrocodone / phenylephrine)
- Bromcomp HC (brompheniramine / hydrocodone / pseudoephedrine)
- bromodiphenhydramine / codeine
- Bromph HD (brompheniramine / hydrocodone / pseudoephedrine)
- brompheniramine / codeine
- brompheniramine / codeine / phenylephrine
- brompheniramine / codeine / phenylpropanolamine
- brompheniramine / codeine / pseudoephedrine
- brompheniramine / dihydrocodeine / phenylephrine
- brompheniramine / dihydrocodeine / pseudoephedrine
- brompheniramine / hydrocodone / phenylephrine
- brompheniramine / hydrocodone / pseudoephedrine
- Bromplex HD (brompheniramine / hydrocodone / pseudoephedrine)
- Brontex (codeine / guaifenesin)
- BroveX CB (brompheniramine / codeine)
- BroveX CBX (brompheniramine / codeine)
- Brovex HC (brompheniramine / hydrocodone / pseudoephedrine)
- BroveX PB C (brompheniramine / codeine / phenylephrine)
- BroveX PB CX (brompheniramine / codeine / phenylephrine)
- bupivacaine / fentanyl
- bupivacaine / hydromorphone
- bupivacaine / sufentanil
- butorphanol
More about Zimhi (naloxone)
- Zimhi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidotes
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.